Cipla Ltd. (CPLFY.PK) announced Tuesday that it has received final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the U.S. Food and Drug Administration (FDA).
from RTT - Biotech https://ift.tt/3gY8Eeq
via IFTTT
No comments:
Post a Comment